117 related articles for article (PubMed ID: 7418929)
1. [A simple method for measuring aldosterone secretion rate using 125I-aldosterone (authors' transl)].
Haruyama K; Yamazaki M; Toki T; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1980 Aug; 56(8):1140-8. PubMed ID: 7418929
[TBL] [Abstract][Full Text] [Related]
2. [A simple method measuring plasma aldosterone by radioimmunoassay without extraction (author's transl)].
Haruyama K; Nakajima K; Fukuchi S; Saito M; Iinuma K
Nihon Naibunpi Gakkai Zasshi; 1977 Jun; 53(6):810-20. PubMed ID: 913713
[TBL] [Abstract][Full Text] [Related]
3. Urine aldosterone radioimmunoassay: validation of a method without chromatography.
Brown RD; Swander A; McKenzie JK
J Clin Endocrinol Metab; 1976 May; 42(5):894-900. PubMed ID: 1270582
[TBL] [Abstract][Full Text] [Related]
4. Is primary aldosteronism underdiagnosed in clinical practice?
Fiquet-Kempf B; Launay-Mignot P; Bobrie G; Plouin PF
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1083-6. PubMed ID: 11903321
[TBL] [Abstract][Full Text] [Related]
5. [A simplified radioimmunoassay for serum aldosterone--non-extraction method with 125I-labeled aldosterone (author's transl)].
Iiunma K; Arakawa Y; Takagi A; Kurata K; Ogihara T
Nihon Naibunpi Gakkai Zasshi; 1977 Jun; 53(6):797-809. PubMed ID: 913712
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].
Yokoyama T; Shimamoto K; Iimura O
Nihon Naibunpi Gakkai Zasshi; 1995 Nov; 71(7):1059-74. PubMed ID: 8582487
[TBL] [Abstract][Full Text] [Related]
7. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
[TBL] [Abstract][Full Text] [Related]
8. A simplified radioimmunoassay for plasma aldosterone.
Walsh PR; Wang MC; Gitterman ML
Ann Clin Lab Sci; 1981; 11(2):138-45. PubMed ID: 7259088
[TBL] [Abstract][Full Text] [Related]
9. [A simple radioimmunoassay determination of urinary aldosterone using 125I-labeled ligand [ALDOCTK-125KIT] and its clinical application].
Kawasaki T; Nakamuta S; Muratani H; Omae T
Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):696-705. PubMed ID: 6489571
[TBL] [Abstract][Full Text] [Related]
10. Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
Morimoto R; Ono Y; Tezuka Y; Kudo M; Yamamoto S; Arai T; Gomez-Sanchez CE; Sasano H; Ito S; Satoh F
Hypertension; 2017 Aug; 70(2):334-341. PubMed ID: 28652474
[TBL] [Abstract][Full Text] [Related]
11. A decreased metabolic clearance rate of aldosterone in benign essential hypertension.
Nowaczynski W; Kuchel O; Genest J
J Clin Invest; 1971 Oct; 50(10):2184-90. PubMed ID: 5116208
[TBL] [Abstract][Full Text] [Related]
12. [A simplified direct radioimmunoassay for urinary aldosterone (author's transl)].
Ogihara T; Nishi K; Hata T; Kumahara Y; Iinuma K; Arakawa Y; Takagi A; Kurata K
Nihon Naibunpi Gakkai Zasshi; 1979 Mar; 55(3):161-70. PubMed ID: 437205
[TBL] [Abstract][Full Text] [Related]
13. [Secretory regulation and episodic secretion of aldosterone in patients with primary aldosteronism (author's transl)].
Ohbuchi S; Murakami T
Nihon Naibunpi Gakkai Zasshi; 1976 Dec; 52(12):1191-201. PubMed ID: 201513
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism: A common and curable form of hypertension.
Young WF
Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
[TBL] [Abstract][Full Text] [Related]
17. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
[TBL] [Abstract][Full Text] [Related]
19. [Primary aldosteronism].
Fardella CE; Mosso LM; Carvajal CA
Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
[TBL] [Abstract][Full Text] [Related]
20. [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
Shkhvatsabaia IK; Pershakova LP; Ustinova SE; Chikhladze NM; Uchitel' IA
Kardiologiia; 1985 Jan; 25(1):16-22. PubMed ID: 2984449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
